If you, in US, know someone for the clinical trial below you can tell him to go to this page and give a try on Thalidomide:
"This study is currently recruiting participants.
Verified by National Cancer Institute (NCI), August 2008
Sponsored by: | Dana-Farber Cancer Institute |
Information provided by: | National Cancer Institute (NCI) |
ClinicalTrials.gov Identifier: | NCT00357500 |
RATIONALE: Drugs used in chemotherapy, such as etoposide and cyclophosphamide, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Thalidomide, celecoxib, and fenofibrate may stop the growth of cancer cells by blocking blood flow to the cancer. Celecoxib also may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Giving combination chemotherapy together with thalidomide, celecoxib, and fenofibrate may kill more cancer cells.
PURPOSE: This phase II trial is studying how well giving etoposide and cyclophosphamide together with thalidomide, celecoxib, and fenofibrate works in treating young patients with relapsed or progressive cancer.
Condition | Intervention | Phase |
Brain and Central Nervous System Tumors Leukemia Lymphoma Neuroblastoma Sarcoma Unspecified Childhood Solid Tumor, Protocol Specific | Drug: celecoxib Drug: cyclophosphamide Drug: etoposide Drug: fenofibrate Drug: thalidomide | Phase II |
Study Type: | Interventional |
Study Design: | Treatment |
Official Title: | Anti-Angiogenic Chemotherapy: A Phase II Trial of the Oral 5-Drug Regimen (Thalidomide, Celecoxib, Fenofibrate, Etoposide and Cyclophosphamide) in Patients With Relapsed or Progressive Cancer |
You can visit the site and there might have some other you can volunteer and make an extra-money. Gook Luck!
No comments:
Post a Comment